Pillar 01
Advanced Manufacturing
Developing specialized pharmaceutical manufacturing capabilities for oncology, biologics, insulin, respiratory therapies, and other high-value medicines.
Home Capabilities Localization
Sudair Pharma was established with a clear objective:
To localize the manufacturing of advanced pharmaceutical products in Saudi Arabia and contribute to a resilient healthcare ecosystem.
Sudair Pharma was established with a clear objective: To localize the manufacturing of advanced pharmaceutical products in Saudi Arabia and contribute to a resilient healthcare ecosystem.
By combining international expertise with local manufacturing capabilities, Sudair Pharma is accelerating pharmaceutical localization while supporting national healthcare priorities, patient access, and economic development.
Supporting Saudi Vision 2030
Reducing Dependence on Imported Medicines
Expanding High-Technology Production
Strengthening National Drug Security
Advancing Local Pharmaceutical Manufacturing
Developing National Scientific Capabilities
Sudair Pharma’s localization initiatives directly support Saudi Vision 2030 and the National Biotechnology Strategy by expanding local manufacturing capabilities, increasing pharmaceutical self-sufficiency, strengthening healthcare resilience, and encouraging innovation across the life sciences sector.
Sudair Pharma is investing in specialized manufacturing facilities that support the localization of complex pharmaceutical products while meeting international quality standards.
Saudi Arabia’s first specialized oncology manufacturing facility, producing advanced oncology and hematology medicines.
Developing a comprehensive insulin manufacturing facility, progressing from secondary packaging toward full formulation, filling, and commercial production.
Building advanced biologics manufacturing capabilities for oncology, immunology, and chronic diseases.
Future production of inhalation therapies, including dry-powder inhalers, metered-dose inhalers, soft-mist devices, and sterile nebulized solutions.
Localization at Sudair Pharma extends beyond manufacturing. It is a comprehensive strategy built around innovation, partnerships, scientific development, and advanced production technologies.
Pillar 01
Developing specialized pharmaceutical manufacturing capabilities for oncology, biologics, insulin, respiratory therapies, and other high-value medicines.
Pillar 02
Working with international pharmaceutical partners to transfer manufacturing knowledge, technical expertise, and production technologies into Saudi Arabia.
Pillar 03
Building partnerships with universities, research institutions, and healthcare organizations to strengthen pharmaceutical innovation and workforce development.
Pillar 04
Investing in local talent, infrastructure, and advanced manufacturing technologies to build long-term pharmaceutical self-sufficiency.
14
Partnerships
Collaborating to Strengthen National Healthcare
Sudair Pharma works with global pharmaceutical companies, government entities, healthcare organizations, and academic institutions to accelerate localization initiatives.
Reducing dependence on imported medicines through advanced local manufacturing.